MetLife declares Q3 2026 dividends on four preferred stock series

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

MetLife Inc declared third-quarter 2026 dividends for its Series A, D, E, and F preferred stocks. The payout includes a quarterly dividend of $0.31471411 for Series A and a semi-annual payment of $29.375 for Series D. Depository shares for Series E and F will receive fractional payouts corresponding to their underlying values.

powered bylight_fuzz_icon
48544740

*this image is generated using AI for illustrative purposes only.

MetLife Inc (NYSE: MET) has declared dividends across four of its preferred stock series for the third quarter of 2026. The insurer announced the payouts for its floating rate and fixed-to-floating rate instruments, with payments scheduled for mid-September.

The declaration covers both quarterly and semi-annual dividend structures, reflecting the varying terms of the different share classes. Shareholders of record as of August 31, 2026, will receive the distributions on September 15, 2026.

Dividend Details

The company specified the following dividend amounts per share:

Preferred Stock Series: Dividend Amount: Frequency: Liquidation Preference:
Series A: $0.31471411 Quarterly $25
Series D: $29.375 Semi-annual $1,000
Series E: $351.5625 Quarterly $25,000
Series F: $296.875 Quarterly $25,000

Series A shares carry a floating rate noncumulative structure with a liquidation preference of $25 per share. Series D shares, which have a 5.875% fixed-to-floating rate non-cumulative structure, pay a semi-annual dividend of $29.375 per share against a $1,000 liquidation preference.

Series E and Series F shares are represented by depositary shares, each representing a 1/1,000th interest in the underlying preferred stock. Holders of Series E depositary shares will receive $0.3515625 per share, while Series F depositary shareholders will receive $0.296875 per share. These series carry liquidation preferences of $25,000 per share each.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the current interest rate environment influence MetLife's decision to maintain or adjust the floating-rate components of its Series A and D preferred stocks in upcoming quarters?

What does the continuation of these dividend payments signal about MetLife's capital adequacy and liquidity position relative to its competitors in the insurance sector?

Given the non-cumulative nature of these preferred shares, how could potential future earnings volatility impact investor confidence in the sustainability of these payouts?

like15
dislike

MetLife board approves $3 billion share buyback authorization

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

MetLife Inc. secured board approval for a $3 billion share repurchase authorization, adding to the $400 million remaining from its April 2025 plan. CEO Michel Khalaf highlighted the company's financial strength and commitment to shareholder value under the New Frontier strategy as key drivers for the move.

powered bylight_fuzz_icon
47523963

*this image is generated using AI for illustrative purposes only.

MetLife Inc. (NYSE: MET) announced that its board of directors has approved a new $3 billion authorization for the repurchase of its common stock. This decision reflects management’s confidence in the insurer’s long-term financial outlook and its continued ability to generate capital. The new authorization is incremental to the approximately $400 million remaining under the company’s prior share repurchase program, which was announced in April 2025.

The total available capital return capacity now stands at approximately $3.4 billion, combining the fresh authorization with the residual balance from the previous plan. This significant allocation underscores MetLife’s commitment to deploying capital where it creates the greatest long-term value for shareholders, consistent with its New Frontier strategy.

"This new share repurchase authorization reflects our confidence in MetLife’s long-term outlook and continued ability to generate capital," said Michel Khalaf, President and Chief Executive Officer of MetLife. "Our diversified business portfolio, financial strength and disciplined execution continue to support durable growth and attractive returns."

Capital Allocation Strategy

MetLife emphasized that its diversified business portfolio and financial strength support this decision. The company stated that disciplined execution continues to support durable growth and attractive returns. Under the New Frontier strategy, MetLife remains committed to optimizing capital deployment to enhance shareholder value.

Metric Value
New Repurchase Authorization $3 billion
Remaining Prior Authorization ~$400 million
Total Available Capacity ~$3.4 billion
Prior Authorization Date April 2025

About MetLife

MetLife, Inc., through its subsidiaries and affiliates, is one of the world’s leading financial services companies. Founded in 1868, it provides insurance, annuities, employee benefits, and asset management to individual and institutional customers. The company operates in more than 40 markets globally, holding leading positions in the United States, Asia, Latin America, Europe, and the Middle East.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might MetLife's increased capital return via share buybacks impact its dividend growth trajectory in the coming fiscal years?

What specific operational metrics or profitability targets under the 'New Frontier' strategy must MetLife achieve to sustain this level of capital deployment?

How will this $3.4 billion repurchase capacity influence MetLife's competitive positioning against peers like Prudential or Aflac in attracting institutional investors?

like16
dislike

More News on MetLife Inc